Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
577
datasets available to search
ShareScore release 0.9.0
Dataset results
577 results for “Cholangiocarcinoma”
Photodynamic Therapy in Locally Advanced Hilar Cholangiocarcinoma
ClinicalTrials.gov study NCT02725073. IPD Sharing: YES. Countries: 1. Publications: 0.
Percutaneous Hepatic Perfusion vs. Cisplatin/Gemcitabine in Patients With Intrahepatic Cholangiocarcinoma
ClinicalTrials.gov study NCT03086993. IPD Sharing: NO. Countries: 1. Publications: 0.
MRI-based Clinico-radiomics Predicting Lymph Node Metastasis Status of Hilar Cholangiocarcinoma
ClinicalTrials.gov study NCT05626127. IPD Sharing: NO. Countries: 1. Publications: 0.
Melphalan for Use With the Hepatic Delivery System Treatment in Patients With Unresectable Hepatocellular Carcinoma or Intra Hepatic Cholangiocarcinoma
ClinicalTrials.gov study NCT02415036. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase I/II Trial of Pemigatinib in Combination With Atezolizumab and Bevacizumab for Treatment of Advanced Cholangiocarcinoma With FGFR2 Fusion
ClinicalTrials.gov study NCT06439485. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Futibatinib in Patients With Advanced Cholangiocarcinoma With FGFR2 Fusion or Rearrangement
ClinicalTrials.gov study NCT05727176. IPD Sharing: NO. Countries: 13. Publications: 0.
Phase II Study of Neoadjuvant Tislelizumab Plus Radiotherapy and GP Chemotherapy for Borderline/Unresectable Hilar Cholangiocarcinoma
ClinicalTrials.gov study NCT07030140. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Effect of 37℃ Non-ionic Contrast Agent During ERCP Procedure in Hilar Cholangiocarcinoma
ClinicalTrials.gov study NCT03104569. IPD Sharing: NO. Countries: 1. Publications: 0.
Expanded Access for the Treatment of Advanced Cholangiocarcinoma With ABC294640 (Yeliva ®)
ClinicalTrials.gov study NCT03414489. IPD Sharing: Not stated. Countries: 0. Publications: 4.
Chart Review: Unresectable/Metastatic Cholangiocarcinoma Treated With Irinotecan, Capecitabine and Celecoxib
ClinicalTrials.gov study NCT00320918. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Lenvatinib, Tislelizumab Combined with Gemcitabine and Cisplatin (GPLET) in the Treatment of Advanced Cholangiocarcinoma
ClinicalTrials.gov study NCT05823311. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of BIND-014 in Patients With Urothelial Carcinoma, Cholangiocarcinoma, Cervical Cancer and Squamous Cell Carcinoma of the Head and Neck
ClinicalTrials.gov study NCT02479178. IPD Sharing: Not stated. Countries: 2. Publications: 0.
En Bloc Resection of the Liver and Pancreas With a "Non-touch" Technique Followed by Liver Transplantation to Improve the Overall Survival in Patients With Non-resectable Hilar Cholangiocarcinoma Beyo
ClinicalTrials.gov study NCT06850753. IPD Sharing: NO. Countries: 1. Publications: 0.
HYPERION CCA: a Phase 2 Trial of Systemic Therapy With or Without Liver-directed Radiation Therapy for Patients With Advanced Intrahepatic Cholangiocarcinoma
ClinicalTrials.gov study NCT06858735. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Ricolinostat, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Unresectable or Metastatic Cholangiocarcinoma
ClinicalTrials.gov study NCT02856568. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Gemcitabine and Capecitabine in Treating Patients With Advanced and/or Inoperable Cholangiocarcinoma or Carcinoma of the Gallbladder
ClinicalTrials.gov study NCT00084942. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Liver Transplantation in Patients With Incidental Hepatocellular-cholangiocarcinoma and Intrahepatic Cholangiocarcinoma: A Single-center Experience
ClinicalTrials.gov study NCT04848805. IPD Sharing: NO. Countries: 1. Publications: 0.
TACE Combined With Tislelizumab in Patients With Advanced Intrahepatic Cholangiocarcinoma
ClinicalTrials.gov study NCT04954781. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Durvalumab Combined With GemCis Neoadjuvant Therapy of Resectable Intrahepatic Cholangiocarcinoma With High Recurrence Risk
ClinicalTrials.gov study NCT05672537. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Second-line Treatment With Apatinib for Advanced Intrahepatic Cholangiocarcinoma
ClinicalTrials.gov study NCT03521219. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.